Northern Trust Corp Statera Biopharma, Inc. Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
BUY
$0.31 - $2.27 $40,875 - $299,310
131,855 Added 335.89%
171,110 $54,000
Q4 2021

Feb 08, 2022
BUY
$2.01 - $4.08 $28,767 - $58,392
14,312 Added 57.38%
39,255 $90,000
Q3 2021

Nov 15, 2021
BUY
$2.29 - $6.24 $57,119 - $155,644
24,943 New
24,943 $58,000

Others Institutions Holding STAB

# of Institutions
4
Shares Held
30K
Call Options Held
0
Put Options Held
0
View Full List

About Statera Biopharma, Inc.

STAB Quotes by TradingView
  • Ticker STAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,295,700
  • Description
  • Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within ...
More about STAB
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email